Take the pledge to vote

For a better tommorow#AajSawaroApnaKal
  • I agree to receive emails from News18

  • I promise to vote in this year's elections no matter what the odds are.
  • Please check above checkbox.

    SUBMIT

Thank you for
taking the pledge

Vote responsibly as each vote counts
and makes a diffrence

Disclaimer:

Issued in public interest by HDFC Life. HDFC Life Insurance Company Limited (Formerly HDFC Standard Life Insurance Company Limited) (“HDFC Life”). CIN: L65110MH2000PLC128245, IRDAI Reg. No. 101 . The name/letters "HDFC" in the name/logo of the company belongs to Housing Development Finance Corporation Limited ("HDFC Limited") and is used by HDFC Life under an agreement entered into with HDFC Limited. ARN EU/04/19/13618
LIVE TV DownloadNews18 App
News18 English
Powered by cricketnext logo
News18 » Business
1-min read

Glenmark Pharma Gets US Health Regulator's Nod for Prostate Cancer Treatment Drug

Quoting IQVIA sales data for the 12 month period ending August 2019, Glenmark said the Zytiga tablets, 250 mg market achieved annual sales of approximately USD 794.1 million.

PTI

Updated:October 17, 2019, 12:18 PM IST
facebookTwitter Pocket whatsapp
Glenmark Pharma Gets US Health Regulator's Nod for Prostate Cancer Treatment Drug
(Photo courtesy: AFP Relaxnews/ ericsphotography / Istock.com)

New Delhi: Drug firm Glenmark Pharmaceuticals on Thursday said it has received final approval from the US health regulator for Abiraterone Acetate tablets, used to treat prostate cancer.

The approved product is a generic version of Zytiga tablets, 250 mg, of Janssen Biotech. "Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate tablets USP, 250 mg," the company said in a regulatory filing.

Quoting IQVIA sales data for the 12 month period ending August 2019, Glenmark said the Zytiga tablets, 250 mg market achieved annual sales of approximately USD 794.1 million.

Glenmark's current portfolio consists of 162 products authorised for distribution in the US marketplace and 46 ANDA's pending approval with the USFDA.

Shares of Glenmark Pharma were trading 0.15 per cent higher at Rs 286.00 apiece on the BSE.

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow News18.com on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you – in real time.

Read full article
Next Story
Next Story

facebookTwitter Pocket whatsapp
Most Active
Company Price Change %Gain
ICICI Bank 498.65 2.66
Yes Bank 68.75 0.81
SBI 306.00 -0.26
Reliance 1,462.75 -0.65
Indiabulls Hsg 211.35 -3.16
Company Price Change %Gain
Narayana Hruda 304.85 1.08
Cipla 451.50 0.73
Yes Bank 68.75 0.73
Indiabulls Hsg 211.20 -3.25
Cholamandalam 309.15 3.99
Top Gainers
Company Price Change %Gain
ICICI Bank 498.65 2.66
IOC 136.85 2.24
Infosys 705.30 2.02
Bajaj Finance 4,210.55 1.59
HDFC Bank 1,273.90 1.30
Company Price Change %Gain
ICICI Bank 498.75 2.67
Infosys 705.35 2.04
Bajaj Finance 4,211.95 1.65
Maruti Suzuki 7,247.10 1.28
HDFC Bank 1,273.70 1.25
Top Losers
Company Price Change %Gain
Bharti Infratel 208.65 -4.38
Vedanta 144.00 -2.96
Zee Entertain 282.00 -2.94
IndusInd Bank 1,375.10 -2.76
UltraTechCement 4,003.40 -2.73
Company Price Change %Gain
Vedanta 143.95 -2.90
IndusInd Bank 1,374.40 -2.79
Coal India 202.25 -2.39
Tata Motors 167.00 -2.11
Bharti Airtel 362.65 -1.59

Live TV

Countdown To Elections Results
To Assembly Elections 2018 Results